Brinker Capital Investments’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,302
| Closed | -$423K | – | 1468 |
|
|
2021
Q3 | $423K | Hold |
2,302
| – | – | 0.01% | 1028 |
|
|
2021
Q2 | $423K | Sell |
2,302
-1,256
| -35% | -$216K | 0.01% | 1087 |
|
|
2021
Q1 | $544K | Sell |
3,558
-7,060
| -66% | -$1.09M | 0.01% | 879 |
|
|
2020
Q4 | $1.66M | Sell |
10,618
-1,822
| -15% | -$234K | 0.03% | 591 |
|
|
2020
Q3 | $1.42M | Buy |
+12,440
| New | +$1.34M | 0.02% | 580 |
|
|
2019
Q4 | – | Sell |
-79
| Closed | -$8K | – | 899 |
|
|
2019
Q3 | $8K | Buy |
+79
| New | +$8.9K | ﹤0.01% | 597 |
|
|
2016
Q4 | – | Sell |
-2
| Closed | – | – | 679 |
|
|
2016
Q3 | $0 | Buy |
+2
| New | +$257 | ﹤0.01% | 650 |
|
|
2016
Q1 | – | Sell |
-7
| Closed | -$1K | – | 729 |
|
|
2015
Q4 | $1K | Hold |
7
| – | – | ﹤0.01% | 554 |
|
|
2015
Q3 | $1K | Buy |
+7
| New | +$1.28K | ﹤0.01% | 444 |
|